NewEdge Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.9M | Buy |
67,317
+7,672
| +13% | +$2.28M | 0.07% | 261 |
|
|
2025
Q4 | $16.3M | Buy |
59,645
+4,903
| +9% | +$1.33M | 0.06% | 298 |
|
|
2025
Q3 | $14.8M | Sell |
54,742
-3,614
| -6% | -$983K | 0.07% | 291 |
|
|
2025
Q2 | $16.1M | Buy |
58,356
+3,195
| +6% | +$869K | 0.08% | 246 |
|
|
2025
Q1 | $14.6M | Buy |
55,161
+2,043
| +4% | +$504K | 0.09% | 235 |
|
|
2024
Q4 | $12.3M | Buy |
53,118
+2,745
| +5% | +$631K | 0.07% | 266 |
|
|
2024
Q3 | $11.1M | Buy |
50,373
+3,436
| +7% | +$711K | 0.07% | 266 |
|
|
2024
Q2 | $9.23M | Buy |
46,937
+1,733
| +4% | +$358K | 0.07% | 276 |
|
|
2024
Q1 | $9.73M | Buy |
45,204
+5,849
| +15% | +$1.23M | 0.08% | 229 |
|
|
2023
Q4 | $8.06M | Buy |
39,355
+8,319
| +27% | +$1.78M | 0.08% | 250 |
|
|
2023
Q3 | $6.21M | Buy |
31,036
+942
| +3% | +$187K | 0.07% | 275 |
|
|
2023
Q2 | $5.58M | Sell |
30,094
-1,967
| -6% | -$364K | 0.06% | 297 |
|
|
2023
Q1 | $6.14M | Buy |
32,061
+4,498
| +16% | +$813K | 0.08% | 255 |
|
|
2022
Q4 | $3.03M | Buy |
27,563
+16,653
| +153% | +$2.89M | 0.08% | 260 |
|
|
2022
Q3 | $1.93M | Sell |
10,910
-1,787
| -14% | -$353K | 0.03% | 437 |
|
|
2022
Q2 | $2.6M | Buy |
12,697
+2,684
| +27% | +$569K | 0.04% | 375 |
|
|
2022
Q1 | $2.38M | Sell |
10,013
-207
| -2% | -$48.6K | 0.04% | 384 |
|
|
2021
Q4 | $2.33M | Buy |
10,220
+1,199
| +13% | +$264K | 0.04% | 401 |
|
|
2021
Q3 | $1.74M | Sell |
9,021
-3,875
| -30% | -$785K | 0.04% | 353 |
|
|
2021
Q2 | $2.74M | Sell |
12,896
-118
| -0.9% | -$24.9K | 0.07% | 249 |
|
|
2021
Q1 | $2.66M | Sell |
13,014
-5,900
| -31% | -$1.16M | 0.08% | 239 |
|
|
2020
Q4 | $3.44M | Sell |
18,914
-12,651
| -40% | -$2.15M | 0.11% | 183 |
|
|
2020
Q3 | $5.28M | Sell |
31,565
-75,898
| -71% | -$12.8M | 0.18% | 119 |
|
|
2020
Q2 | $17.5M | Buy |
107,463
+15,187
| +16% | +$2.72M | 0.68% | 40 |
|
|
2020
Q1 | $16M | Buy |
92,276
+5,738
| +7% | +$1.14M | 0.77% | 32 |
|
|
2019
Q4 | $17.4M | Buy |
86,538
+4,939
| +6% | +$1.01M | 0.69% | 34 |
|
|
2019
Q3 | $17.3M | Buy |
81,599
+10,503
| +15% | +$2.19M | 0.77% | 29 |
|
|
2019
Q2 | $13.8M | Buy |
71,096
+1,739
| +3% | +$321K | 0.85% | 27 |
|
|
2019
Q1 | $11.4M | Buy |
69,357
+8,476
| +14% | +$1.5M | 0.74% | 35 |
|
|
2018
Q4 | $11.5K | Sell |
60,881
-5,204
| -8% | -$961K | 0.74% | 24 |
|
|
2018
Q3 | $11.3M | Buy |
66,085
+5,944
| +10% | +$1M | 0.86% | 28 |
|
|
2018
Q2 | $9.86K | Buy |
60,141
+1,449
| +2% | +$237K | 0.9% | 26 |
|
|
2018
Q1 | $9.26M | Buy |
58,692
+6,907
| +13% | +$1.1M | 1.06% | 22 |
|
|
2017
Q4 | $7.86M | Buy |
51,785
+2,856
| +6% | +$407K | 1.06% | 24 |
|
|
2017
Q3 | $6.75M | Buy |
48,929
+4,687
| +11% | +$592K | 1.05% | 25 |
|
|
2017
Q2 | $5.49M | Buy |
44,242
+5,092
| +13% | +$609K | 0.94% | 29 |
|
|
2017
Q1 | $4.61M | Buy |
39,150
+36,797
| +1,564% | +$4.43M | 1.05% | 33 |
|
|
2016
Q4 | $271K | Buy |
+2,353
| New | +$262K | 0.08% | 203 |
|
Other funds holding CME
VCM
VPM
NewEdge Advisors's CME Position: Q1 2026 in Review
NewEdge Advisors increased its CME Group (CME) stake by 13% in Q1 2026, buying an estimated $2.28M and bringing the position to 67,317 shares worth $19.9M. The position accounts for 0.07% of the portfolio, ranked #261.
NewEdge Advisors first reported a position in CME in Q4 2016 and has held it in 38 quarters since. 1,796 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- NewEdge Advisors held 67,317 shares of CME Group worth $19.9M as of Q1 2026.
- NewEdge Advisors bought 7,672 CME Group shares in Q1 2026, an estimated $2.28M.
- CME Group made up 0.07% of NewEdge Advisors's portfolio in Q1 2026, its #261 holding.
- NewEdge Advisors first reported a position in CME Group in Q4 2016 and has held it in 38 quarters since.
- 1,796 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.